Detalhe da pesquisa
1.
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Br J Cancer
; 130(5): 788-797, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200233
2.
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; : e31039, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689540
3.
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma.
Pediatr Blood Cancer
; 71(1): e30743, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37885116
4.
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 70(8): e30418, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199022
5.
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.
Cancer
; 128(21): 3775-3783, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36101004
6.
Anatomic patterns of relapse and progression following treatment with 131 I-MIBG in relapsed or refractory neuroblastoma.
Pediatr Blood Cancer
; 69(2): e29396, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662499
7.
Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 69(9): e29616, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35188340
8.
Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource-limited countries.
Pediatr Blood Cancer
; 69(4): e29568, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084087
9.
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.
Pediatr Blood Cancer
; 68(10): e29117, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028986
10.
Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary Malignancy.
J Pediatr Hematol Oncol
; 42(7): e647-e654, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815884
11.
Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma.
Biol Blood Marrow Transplant
; 25(10): 2031-2039, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31199983
12.
Congenital malformation syndromes associated with peripheral neuroblastic tumors: A systematic review.
Pediatr Blood Cancer
; 66(10): e27901, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31264798
13.
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 66(8): e27819, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31115156
14.
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
Pediatr Blood Cancer
; 66(7): e27736, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30968542
15.
Neuroblastoma: clinical and biological approach to risk stratification and treatment.
Cell Tissue Res
; 372(2): 195-209, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572647
16.
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.
Eur J Nucl Med Mol Imaging
; 45(2): 292-305, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28940046
17.
Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.
Pediatr Blood Cancer
; 65(5): e26940, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29350464
18.
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Pediatr Blood Cancer
; 65(7): e27023, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603591
19.
Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Cancer
; 123(21): 4224-4235, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696504
20.
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28383813